We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$30.4B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$841M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
10.11%
Holding
1,992
New
240
Increased
827
Reduced
644
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$151M |
| 2 |
Applied Materials
AMAT
|
+$145M |
| 3 |
Intuit
INTU
|
+$142M |
| 4 |
Humana
HUM
|
+$115M |
| 5 |
Sherwin-Williams
SHW
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$177M |
| 2 |
Exelon
EXC
|
+$128M |
| 3 |
NXP Semiconductors
NXPI
|
+$124M |
| 4 |
UnitedHealth
UNH
|
+$119M |
| 5 |
PayPal
PYPL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.39% |
| 2 | Healthcare | 14.41% |
| 3 | Financials | 14.4% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1326
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.58M | 0.01% |
12,774
-22,914
| -64% | -$2.05M |
|
1327
Tilray
TLRY
$479M
| $1.58M | 0.01% |
9,237
+5,301
| +135% | +$1.1M |
|
1328
Sonos
SONO
$1.75B
| $1.57M | 0.01% |
+100,654
| New | +$1.4M |
|
|
NEWR
1329
DELISTED
New Relic, Inc.
NEWR
| $1.57M | 0.01% |
+23,927
| New | +$1.55M |
|
1330
BlackLine
BL
$1.69B
| $1.57M | 0.01% |
30,422
-26,147
| -46% | -$1.31M |
|
1331
Methanex
MEOH
$4.32B
| $1.57M | 0.01% |
40,606
-54,308
| -57% | -$2.04M |
|
1332
Independent Bank Corp
IBCP
$776M
| $1.56M | 0.01% |
68,760
| – | – |
|
1333
National Vision
EYE
$1.6B
| $1.55M | 0.01% |
47,780
-109,422
| -70% | -$3.01M |
|
1334
Carpenter Technology
CRS
$30B
| $1.55M | 0.01% |
31,053
-70,673
| -69% | -$3.63M |
|
1335
Brookfield
BN
$102B
| $1.54M | 0.01% |
74,769
-68,097
| -48% | -$1.36M |
|
1336
Ovintiv
OVV
$17.5B
| $1.54M | 0.01% |
65,733
+233
| +0.4% | +$4.99K |
|
1337
First Citizens BancShares
FCNCA
$24.6B
| $1.54M | 0.01% |
+2,888
| New | +$1.46M |
|
1338
Advanced Micro Devices
AMD
$851B
| $1.54M | 0.01% |
33,484
-13,713
| -29% | -$505K |
|
1339
Cameco
CCJ
$38.3B
| $1.52M | 0.01% |
171,151
-94,696
| -36% | -$875K |
|
|
CSW
1340
CSW Industrials
CSW
$4.71B
| $1.52M | 0.01% |
19,794
+10,226
| +107% | +$735K |
|
1341
First Financial Bancorp
FFBC
$3.55B
| $1.52M | 0.01% |
59,792
-132,659
| -69% | -$3.23M |
|
1342
Alaska Air
ALK
$5.15B
| $1.51M | 0.01% |
22,301
-89,528
| -80% | -$6.11M |
|
|
CALY
1343
Callaway Golf Company
CALY
$3.26B
| $1.51M | 0.01% |
71,184
-182,009
| -72% | -$3.73M |
|
1344
NeoGenomics
NEO
$1.81B
| $1.5M | ﹤0.01% |
+51,451
| New | +$1.23M |
|
1345
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $1.5M | ﹤0.01% |
48,733
+27,926
| +134% | +$820K |
|
1346
Compass Minerals
CMP
$1.24B
| $1.48M | ﹤0.01% |
24,200
-12,199
| -34% | -$692K |
|
|
PLAN
1347
DELISTED
Anaplan, Inc.
PLAN
| $1.47M | ﹤0.01% |
28,108
+2,810
| +11% | +$139K |
|
1348
US Physical Therapy
USPH
$1.14B
| $1.47M | ﹤0.01% |
12,862
+7,915
| +160% | +$986K |
|
|
PRNB
1349
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.47M | ﹤0.01% |
+26,844
| New | +$1M |
|
1350
CALL
Teladoc Health
TDOC
$1.58B
| $1.47M | ﹤0.01% |
+17,500
| New | +$1.33M |
|
Similar funds
Man Group's Q4 2019 Portfolio in Review
As of Q4 2019, Man Group held 1,992 positions worth $30.4B, up 13% from $26.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Man Group's Q4 2019 filing shows 240 new, 827 increased, 644 reduced and 177 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M. The largest sale was Expedia Group, an estimated $177M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Man Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M.
- Man Group added most to Procter & Gamble in Q4 2019, an estimated $151M increase.
- Man Group's biggest Q4 2019 reduction was Expedia Group, cutting an estimated $177M.
- Man Group fully exited Celgene Corp in Q4 2019, selling an estimated $47.9M.
- Man Group's ten largest holdings make up 10% of its $30.4B portfolio in Q4 2019.
- Man Group opened 240 new positions and closed 177 in Q4 2019.
- Man Group's portfolio value rose 13% quarter-over-quarter to $30.4B.
Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.